A 38-year-old woman with profound mental retardation since birth, but no evidence of genetic
or metabolic defect, was treated with lithium carbonate to alleviate aggressive behaviour. …

… The patients in this study, like those in other recent reports (eg, Naylor and Smith I98 1;
Narsapur and Naylor 1983; Thomas and Callender 1985), were patients who had failed to make …

Marine macrolides that selectively disrupt cell cycle events continue to occupy a central position
as lead compounds in the ongoing search for novel anticancer agents,[1, 2] highlighted …

A new guitarfish, Rhinobatos borneensis sp. nov., is described from material collected at fish
markets in Malaysian Borneo (South China Sea). This ray, which is almost plain coloured …

Methylene blue, 15 mg/day, was compared with placebo in treatment of severe depressive
illness. The 3-week trial was designed to avoid bias by placebo response and also to avoid …

… The rise in Na-K ATPase with lithium and its final level correlate with the clinical course of
the illness over the following 12 months (Naylor et al. 1976b; Johnston et al. 1980). Blocking …

… Naylor & Scott (1980) described five recurrent bipolar manic-depressive patients in whom
depot … NAYLOR,G. & Sco'rr, C. (1980) Depot injections for affective disorders. … Naylor …

Molecular and morphological data show that the pelagic eagle rays of the genus Aetobatus
form a distinct family-level grouping separate from the true eagle rays, Aetomylaeus and …

… in the aetiology of manic depressive psychosis (Naylor and Smith 198 la). Methods of …
therapeutic effect in both mania and depression (Naylor and Smith 1981b). Methylene blue will …

… of the aetiology of this disorder and one of these proposes that raised tissue levels of
vanadium are aetiologically related to both the manic and depressive phases of the illness (Naylor …